Merck & Co., Inc.
An institutional investment manager in RAHWAY, NJ. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 7, 2026. SEC CIK 310158.
- Reported value$526.4m
- Positions13
Holdings: 13 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Personalis IncPSNL | COM | 71535D106 | 188 | 35.8% | 14,044,943 | Unchanged | |
| Moderna IncMRNA | COM | 60770K107 | 162 | 30.7% | 2,308,190 | Unchanged | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 88.5 | 16.8% | 772,165 | Unchanged | |
| Aktis Oncology IncAKTS | COM | 01021M104 | 30.7 | 5.8% | 952,844 | Unchanged | |
| Eikon Therapeutics IncEIKN | COM | 282564103 | 21.7 | 4.1% | 1,666,666 | Unchanged | |
| Entrada Therapeutics IncTRDA | COM | 29384C108 | 12.8 | 2.4% | 1,739,768 | New+1,739,768 | |
| Sutro Biopharma IncSTRO | COM | 869367201 | 9.0 | 1.7% | 272,351 | New+272,351 | |
| Alector IncALEC | COM | 014442107 | 7.1 | 1.4% | 3,545,719 | Unchanged | |
| Evaxion Biotech A/SEVAX | SPONSORED ADS | 29970R303 | 3.8 | 0.7% | 1,214,126 | New+1,214,126 | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 1.7 | 0.3% | 93,414 | Unchanged | |
| Xilio Therapeutics IncXLO | COM | 98422T209 | 1.0 | 0.2% | 105,982 | Unchanged | |
| Tuhura Biosciences IncHURA | COM | 898920103 | 0.0 | <0.1% | 19,445 | Unchanged | |
| Neuphoria Therapeutics IncNEUP | COM | 64136E102 | 0.0 | <0.1% | 10,027 | Unchanged |
Sold out: 4 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc | COM | 14216R101 | 0.0 | 0.0% | 0 | Sold out−1,473,240 | |
| Entrada Therapeutics Inc | COM | 29384C908 | 0.0 | 0.0% | 0 | Sold out−1,739,768 | |
| Evaxion Biotech A/S | SPONSORED ADS | 29970R204 | 0.0 | 0.0% | 0 | Sold out−1,214,126 | |
| Sutro Biopharma Inc | COM | 869367102 | 0.0 | 0.0% | 0 | Sold out−272,351 |
Source: SEC EDGAR, Form 13F-HR, accession 0000310158-26-000210 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.